بوابة الشروق
بوابة الشروق
Ready to play
Ready to play
The Egyptian Drug Authority has confirmed that the localization of the pharmaceutical industry in Egypt has reached 91%, meaning that 91 out of every 100 medicine packages circulating in the local market are manufactured within Egyptian factories. These factories comprise more than 180 facilities with 2,370 production lines covering various pharmaceutical forms. Egyptian medicine exports increased by more than 21% during 2025, rising from 1.071 billion Egyptian pounds in 2024 to 1.3 billion in 2025. Export commitments include maintaining sufficient stock for six months prior to export. Egypt is also focused on opening new international markets in cooperation with multiple countries. Additionally, officials from the Egyptian Drug Authority denied any approval of new price increases for medicines in January, emphasizing that the Authority is the sole entity responsible for setting the prices of pharmaceutical products according to approved policies.
Notice: This Is an AI-Generated Summary
Comments (0)